Authors: Madhukar Pai, MD, PhD—Author and Series Editor
Number of pages: 5
Download (2018, pdf, 313kb)
Overview: This article describes the Initiative for Promoting Affordable, Quality TB tests (IPAQT; www.ipaqt.org), a coalition of private laboratories in India, supported by industry and non-profit groups, that has made several WHO-endorsed TB tests available at more affordable prices to patients in the private sector. General practitioner who manage TB should avoid inaccurate blood-based tests and use WHO-endorsed sputum tests for TB, including LED fluorescence smear microscopy, liquid cultures, line probe assays, and automated, cartridge-based molecular tests (i.e., Xpert MTB/RIF). These tests are validated and backed by strong evidence and WHO policy recommendations. Thanks to IPAQT, their prices have been reduced considerably in the Indian private sector.
View and download slides